This 2nd position paper of our 2023 Medical Series proposes 5 recommendations and several tools to develop High-Performance Strategic Medical Plans.
News
With 3 million people affected in France, rare diseases are a major public health issue. 25% of...
This position paper covers the following key issues:
French health authorities intent – cautiously – to facilitate the development of the biosimilars market by: This...